These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines. Sairenji T, Nguyen QV, Woda B, Humphreys RE. AIDS Res; 1986 Dec 15; 2 Suppl 1():S57-60. PubMed ID: 3030348 [Abstract] [Full Text] [Related]
3. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J, Pai S, Cotter M, Robertson ES. Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337 [Abstract] [Full Text] [Related]
4. A novel early antigen associated with Epstein-Barr virus productive cycle. Freemer CS, Bertoni G, Takagi S, Sairenji T. Virology; 1993 May 15; 194(1):387-92. PubMed ID: 8386883 [Abstract] [Full Text] [Related]
5. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, Middeldorp JM. J Med Virol; 2007 Nov 15; 79(11):1710-21. PubMed ID: 17854043 [Abstract] [Full Text] [Related]
6. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH, Wills A, Reece E, Fox Z. Can Med Assoc J; 1981 Oct 15; 125(8):845-9. PubMed ID: 6272957 [Abstract] [Full Text] [Related]
7. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo. Edson CM, Cohen LK, Henle W, Strominger JL. J Immunol; 1983 Feb 15; 130(2):919-24. PubMed ID: 6294181 [Abstract] [Full Text] [Related]
8. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia]. Okano M. Hokkaido Igaku Zasshi; 1986 Jul 15; 61(4):584-92. PubMed ID: 3019855 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells. Daibata M, Sairenji T. Virology; 1993 Oct 15; 196(2):900-4. PubMed ID: 8396819 [Abstract] [Full Text] [Related]
10. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M, Myc A, Matej H, Rudzka L. Arch Immunol Ther Exp (Warsz); 1983 Oct 15; 31(6):871-8. PubMed ID: 6331340 [Abstract] [Full Text] [Related]
11. Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues. Takasaka N, Tajima M, Okinaga K, Satoh Y, Hoshikawa Y, Katsumoto T, Kurata T, Sairenji T. Virology; 1998 Aug 01; 247(2):152-9. PubMed ID: 9705908 [Abstract] [Full Text] [Related]
12. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate. Prachová K, Roubal J, Vonka V, Brichácek B, Reifová M. Acta Virol; 1983 Jul 01; 27(4):329-36. PubMed ID: 6138996 [Abstract] [Full Text] [Related]
13. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines. Szekely L, Pokrovskaja K, Klein G. Cell Growth Differ; 1997 May 01; 8(5):599-609. PubMed ID: 9149911 [Abstract] [Full Text] [Related]
14. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Niller HH, Wolf H, Minarovits J. Autoimmunity; 2008 May 01; 41(4):298-328. PubMed ID: 18432410 [Abstract] [Full Text] [Related]
15. Enzyme-linked immunosorbent assay for antibodies to Epstein-Barr virus-associated early antigens and the viral capsid antigen. Dölken G, Boldt C, Lange W, Weitzmann U, Löhr GW, Rosén A. Cancer Detect Prev; 1983 May 01; 6(1-2):287-92. PubMed ID: 6309387 [Abstract] [Full Text] [Related]
16. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M. Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978 [Abstract] [Full Text] [Related]
17. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. Sairenji T, Reisert PS, Spiro RC, Connolly T, Humphreys RE. J Exp Med; 1985 May 01; 161(5):1097-111. PubMed ID: 2580934 [Abstract] [Full Text] [Related]
18. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus]. Xia Q, Meng G, Ai Y. Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug 01; 33(4):235-6. PubMed ID: 11717892 [Abstract] [Full Text] [Related]
19. Detection of an idiotope on a human monoclonal autoantibody by monoclonal anti-idiotypic antibody and its relationship to Epstein-Barr virus-induced autoimmunity. Garzelli C, Incaprera M, Bazzichi A, Falcone G. Autoimmunity; 1992 Aug 01; 11(3):171-7. PubMed ID: 1315162 [Abstract] [Full Text] [Related]
20. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA). Garzelli C, Pacciardi A, Carmignani M, Conaldi G, Basolo F, Falcone G. Immunol Lett; 1989 Sep 01; 22(3):211-6. PubMed ID: 2478456 [Abstract] [Full Text] [Related] Page: [Next] [New Search]